Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
一项针对 III 期不可切除非小细胞肺癌患者的 I/II 期研究显示，放疗和化疗联合伊匹木单抗序贯纳武利尤单抗治疗可导致剂量限制性肺毒性。
期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2023.01.006
Liveringhouse, Casey L; Latifi, Kujtim; Asous, Amalin G; Lam, Nghi B; Rosenberg, Stephen A; Dilling, Thomas J; MacMillan, Gretchen V; Chiappori, Alberto A; Haura, Eric B; Creelan, Ben; Gray, Jhanelle E; Tanvetyanon, Tawee; Shafique, Michael R; Saltos, Andreas N; Weiner, Ashley A; Clarke, Jeffrey; Kelsey, Christopher R; Kim, Sungjune; Caudell, James J; Rose, Trevor A; Conejo-Garcia, Jose R; Li, Jiannong; Schell, Michael J; Antonia, Scott J; Perez, Bradford A
